Cargando…
Update on GPCR-based targets for the development of novel antidepressants
Traditional antidepressants largely interfere with monoaminergic transport or degradation systems, taking several weeks to have their therapeutic actions. Moreover, a large proportion of depressed patients are resistant to these therapies. Several atypical antidepressants have been developed which i...
Autores principales: | Mantas, Ioannis, Saarinen, Marcus, Xu, Zhi-Qing David, Svenningsson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960420/ https://www.ncbi.nlm.nih.gov/pubmed/33589739 http://dx.doi.org/10.1038/s41380-021-01040-1 |
Ejemplares similares
-
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP-363856
por: Saarinen, Marcus, et al.
Publicado: (2022) -
Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP- 363856
por: Saarinen, Marcus, et al.
Publicado: (2022) -
A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Daly, Ella J, et al.
Publicado: (2007) -
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
por: Wei, Yan, et al.
Publicado: (2021) -
Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?
por: Toba-Oluboka, Temi, et al.
Publicado: (2022)